Vitiligo. disorders of pigmentation
Conditions
Interventions
Intervention 1: Intervention group: A diseased patch of patient dermabrade and a gel containing cells is placed on the area and bandaged. Intervention 2: Control group: A patch of patient dermabrade a
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Having no treatment within past 6 months No pregnancy or breast-feeding Have a diagnosis of vitiligo with depigmented patch more than 5 cm despite receiving at least 3 months active treatment No infection at recipient site No history of keloid and or koebner phenomenon No history of active hepatitis the B, C, or AIDS No active uncontrolled chronic systemic disease
Exclusion criteria
Exclusion criteria: Vitiligo patients with active or progressive disease within last 12 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Repigmentation rate. Timepoint: Before, 1, 3 and 6 months after treatment. Method of measurement: The amount of melanin in the treated areas compared to before treatment using a maxameter device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSona Zare
Skin and Stem Cell Research Center, Tehran University of Medical Sciences
Outcome results
None listed